Biogen
Phone: +1 781-464-2000
| Formerly | Biogen Idec Inc. (2003–2015) |
|---|---|
| Type | Public company |
| Traded as |
|
| Industry | Biotechnology |
| Founded | 1978 (1978) |
| Founders | Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO) |
| Products | Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza |
| Revenue |  US$10.981 billion (2021) |
| Operating income | US$2.84 billion (2021) |
| Net income | US$1.727 billion (2021) |
| Total assets | US$23.877 billion (2021) |
| Total equity |  US$10.96 billion (2021) |
| Number of employees | 9,100 (2020) |
| Website | biogen.com |
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
For detailed contact information visit location pages below.
Biogen's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Biogen
-
BiogenWerving
-
BiogenWervingPostnatale depressieVerenigde Staten
-
BiogenWervingGezonde vrijwilligerVerenigde Staten
-
BiogenWerving
-
BiogenWerving
-
BiogenWervingPrimaire membraneuze nefropathieAustralië, Taiwan, China, Verenigde Staten, Japan, Argentinië, Brazilië, Maleisië, Indië, Zuid -Korea
-
BiogenVoltooid
-
BiogenActief, niet wervendSpinale spieratrofieVerenigde Staten, Hongarije, Japan, Italië, Duitsland
-
BiogenAanmelden op uitnodigingSubacute cutane lupus erythematosus | Chronische cutane lupus erythematosusVerenigde Staten, Brazilië, Spanje, Taiwan, Canada, Frankrijk, Duitsland, Japan, Italië, Colombia, Verenigd Koninkrijk, Servië, Chili, Filippijnen, Bulgarije, China, Zweden, Zwitserland, Mexico, Zuid -Korea, Argentinië, Hongarije, Sl... en meer